These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 7631297)

  • 21. [Vasodilators. Clinical effect in peripheral vascular disorders. A survey of the literature].
    Hallén LG
    Lakartidningen; 1965 Sep; 62(39):3149-52. PubMed ID: 5330352
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of labyrinth diseases using delayed-action peripheral vasodilators].
    Menon AD; Ganança MM; Albernaz PL; Lanzellotti WP; Maudonnet OA
    Hospital (Rio J); 1969 Oct; 76(4):1217-20. PubMed ID: 4391343
    [No Abstract]   [Full Text] [Related]  

  • 23. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
    Mohler ER; Klugherz B; Goldman R; Kimmel SE; Wade M; Sehgal CM
    Vasc Med; 2000; 5(4):231-7. PubMed ID: 11213235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug therapy of peripheral arterial occlusive disease].
    Mahler F
    Schweiz Med Wochenschr; 1981 May; 111(18):637-40. PubMed ID: 7244587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Peripheral vasodilators: from the hemodynamic effect to clinical benefit].
    Chamontin B; Boccalon H
    Therapie; 1995; 50(2):89-93. PubMed ID: 7631297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pentoxifylline and intermittent claudication: critical analysis of clinical trials].
    Charansonney OL; Spriet A
    Therapie; 1995; 50(1):73-8. PubMed ID: 7754482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentoxifylline and intermittent claudication: review of clinical trials and cost-effectiveness analyses.
    Gillings DB
    J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S44-50. PubMed ID: 8699861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease].
    Scheffler A; Rieger H
    Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):639-44. PubMed ID: 10666827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale for the use of antiplatelet drugs in patients with peripheral vascular disease.
    Violi F; Balsano F
    Clin Trials Metaanal; 1994 Apr; 29(1):81-7. PubMed ID: 10150187
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.